ACADIA Pharmaceuticals Inc (ACAD)
US$ 17.2-1.83%
Price Chart
Key Statistics
Market Cap
$ 3.82B
P/E Ratio
16.17
Revenue (TTM)
$ 996.28M
Volume
1.31M
52W High
$ 25.23
52W Low
$ 13.40
Dividend Yield
0.00%
Beta
0.65
Technicals
50-Day MA
18.181
200-Day MA
17.25
52 Week High
25.23
52 Week Low
13.4
About ACAD
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United State.
Employees
653
Headquarters
San Diego, CA
CEO
Ms. Catherine E. Owen Adams
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg